{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Blayney MC"],"funding":["THIS Institute"],"pagination":["980-989"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8942655"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["128(6)"],"pubmed_abstract":["<h4>Background</h4>Patients with COVID-19 can require critical care for prolonged periods. Patients with persistent critical Illness can have complex recovery trajectories, but this has not been studied for patients with COVID-19. We examined the prevalence, risk factors, and long-term outcomes of critically ill patients with COVID-19 and persistent critical illness.<h4>Methods</h4>This was a national cohort study of all adults admitted to Scottish critical care units with COVID-19 from March 1, 2020 to September 4, 20. Persistent critical illness was defined as a critical care length of stay (LOS) of ≥10 days. Outcomes included 1-yr mortality and hospital readmission after critical care discharge. Fine and Gray competing risk analysis was used to identify factors associated with persisten"],"journal":["British journal of anaesthesia"],"pubmed_title":["Prevalence, characteristics, and longer-term outcomes of patients with persistent critical illness attributable to COVID-19 in Scotland: a national cohort study."],"pmcid":["PMC8942655"],"funding_grant_id":["PD-2019-02-016"],"pubmed_authors":["Paton M","Lone NI","McPeake J","Puxty K","Hall R","Martin C","of the Scottish Intensive Care Society Audit Group","Haddow C","Chan Seem R","Donaldson L","Blayney MC","Stewart NI","Kaye CT"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence, characteristics, and longer-term outcomes of patients with persistent critical illness attributable to COVID-19 in Scotland: a national cohort study.","description":"<h4>Background</h4>Patients with COVID-19 can require critical care for prolonged periods. Patients with persistent critical Illness can have complex recovery trajectories, but this has not been studied for patients with COVID-19. We examined the prevalence, risk factors, and long-term outcomes of critically ill patients with COVID-19 and persistent critical illness.<h4>Methods</h4>This was a national cohort study of all adults admitted to Scottish critical care units with COVID-19 from March 1, 2020 to September 4, 20. Persistent critical illness was defined as a critical care length of stay (LOS) of ≥10 days. Outcomes included 1-yr mortality and hospital readmission after critical care discharge. Fine and Gray competing risk analysis was used to identify factors associated with persisten","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jun","modification":"2025-04-18T12:17:30.339Z","creation":"2025-04-06T21:51:16.073Z"},"accession":"S-EPMC8942655","cross_references":{"pubmed":["35465954"],"doi":["10.1016/j.bja.2022.03.017"]}}